Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Martin Galindo/Long Visual Press/Universal Images Group via Getty Images

Moderna on Monday released trial results for its coronavirus vaccine for children aged 6 to 11, saying it provides a "robust" immune response after two doses.

Why it matters: Moderna said it will officially submit the results to the Food and Drug Administration for authorization in "the near term," meaning we could soon see two coronavirus vaccines available to protect approximately 28 million more kids in the U.S.

  • The FDA is set to authorize the Pfizer-BioNTech vaccine for children soon. Regulators said last week that the benefits of the vaccine outweigh the risks for children between the ages of 5 and 11.

The big picture: The Biden administration released a plan last week to "quickly" vaccinate children between the ages of 5 and 11 after the FDA and the Centers for Disease Control and Prevention authorize a vaccine for that age group.

How it works: Moderna's trial examined "4,753 participants who were 6 to less than 12 years of age," the company said.

  • Trial participants received two 50 micrograms vaccine doses, half the dose given to adults.
  • Most side effects "were mild or moderate in severity." The most common were fatigue, headache, fever and injection site pain.

What to watch: Moderna said it will "soon" submit its results to the FDA, the European Medicines Agency and other global health regulators.

Go deeper: COVID vaccines for kids are getting closer

Go deeper

Dec 6, 2021 - Health

CDC raises travel advisories for France, Portugal to highest level amid COVID surge

Angus Mordant/Bloomberg via Getty Images

The Centers for Disease Control and Prevention raised COVID-19 travel advisories to their highest levels for a number of countries on Monday, including France and Portugal.

Why it matters: The detection of the new Omicron variant last month has spurred fears of a new wave of virus infections.

Dec 6, 2021 - Health

Cruise ship COVID outbreak: Louisiana officials find "probable" Omicron case

The Norwegian Breakaway cruise ship. Photo: Gerard Bottino/SOPA Images/LightRocket via Getty Images

Louisiana health authorities said a suspected Omicron case was one of 17 confirmed COVID-19 infections among the passengers and crew of a Norwegian Cruise Lines ship that returned to New Orleans Sunday.

Driving the news: The Norwegian Breakaway departed New Orleans on Nov. 28 with more than 3,200 people on board, before making stops in Belize, Honduras and Mexico, according to a Louisiana Department of Health statement.

Gov. Hochul will order some NY hospitals to halt elective surgeries

New York State Gov. Kathy Hochul COVID-19 addresses rising cases in the state and the new variant Omicron at a press conference in November. Photo: Lev Radin/Pacific Press/LightRocket via Getty Images

New York Gov. Kathy Hochul announced on Monday that some state hospitals will be ordered to halt certain elective surgeries in an effort to combat a recent COVID-19 surge, Hochul said at a press conference.

Why it matters: New York has struggled with hospital capacity throughout the pandemic and postponed nonessential procedures before.